Industry Outlook: Healthcare & Life Sciences — Week of March 23, 2026

Market Outlook

• AI moves from pilots to system‑level design. HIMSS26 commentary and Fierce Healthcare coverage converge on the same message: health systems and payers are being pushed to move beyond isolated AI point solutions toward intentional, enterprise‑wide AI design. This includes governance, model lifecycle management, and integration into EHR, revenue cycle, and patient access workflows rather than standalone tools. Vendors and providers that can articulate a coherent AI operating model will increasingly win over those selling single‑use algorithms.
• Payer and provider realignments reshape tech buyers. Providence’s exploration of a health plan sale and the Sutter–Allina $26B merger highlight accelerating structural shifts in who buys and governs health IT. Consolidation increases the likelihood of multi‑state platforms, centralized data strategies, and unified digital front doors, while divestitures can fragment decision‑making and delay large programs. For vendors, these moves change account strategies; for health systems, they raise the stakes on scalable, interoperable architectures that can survive M&A.
• Women’s and maternal health emerge as growth arenas. New data peg the women’s health market at $430–$440B with 6–8% annual growth through 2030, while maternal health and doula‑network startups attract fresh capital. Fertility‑adjacent platforms like PreSeed and content around supplements and donor shortages signal continued demand for tech‑enabled reproductive care. This is a fertile segment for digital therapeutics, remote monitoring, and personalized care journeys, but it will demand robust privacy and nuanced clinical governance.

Discussion: CTOs should assume AI and data platforms are now core infrastructure, not experiments, and stress‑test them against a backdrop of payer/provider restructuring and fast‑growing women’s health demand.

Headwinds

• Medical device and cloud controls targeted by attackers. The FBI’s takedown of MOIS‑linked Handala sites followed the group’s use of compromised credentials to access Stryker’s Microsoft Intune environment and wipe devices. This incident shows that adversaries are pivoting from data exfiltration to operational disruption via device management and endpoint control planes. For any organization with connected devices or remote management agents, the blast radius now includes care delivery itself, not just PHI loss.
• Privacy, cybersecurity and fraud scrutiny intensify. CMS is launching its CRUSH initiative to enlist the public in Medicare and Medicaid fraud detection while simultaneously finalizing rules to phase out fax and paper claims documentation, and legal/compliance experts are flagging an evolving privacy and cyber landscape. This creates a dual pressure: richer, more digital data streams for payers and regulators, and a lower tolerance for security lapses or opaque billing patterns. Fraud analytics and auditability are becoming table stakes for digital health platforms.
• Economic and labor pressures constrain IT spend. Hospitals face rising bad debt and are being urged by Kaufman Hall to be more strategic with capital and operating expenditure, even as ACA enrollees see higher costs and nursing labor unrest continues. These macro and workforce pressures will make boards more conservative about large greenfield IT projects and more demanding about clear ROI. AI and telehealth proposals that can’t show near‑term operational or revenue improvements will struggle to get funded.

Discussion: CTOs should harden identity and device‑management stacks, build fraud‑ and audit‑ready data flows, and reframe major initiatives in terms of measurable cost, access, or labor benefits within 12–24 months.

Tailwinds

• Verily’s $300M raise validates precision health AI. Verily’s $300M round, alongside its move out from under Alphabet, signals continued investor conviction in AI‑driven precision health, data platforms, and clinical decision support. This capital will likely flow into longitudinal data integration, real‑world evidence generation, and disease‑specific AI programs. It also sets a benchmark for how to position regulated and semi‑regulated software assets at the intersection of life sciences and care delivery.
• Voice and remote workforce tech unlock access gains. Saluja Medical Associates’ ROI from a remote workforce platform and MedCity’s coverage of voice AI ending the ‘voicemail bottleneck’ show that relatively mature technologies—cloud contact centers, automation, and distributed back‑office teams—are delivering tangible access and throughput improvements. These wins are achievable without bleeding‑edge models and can free up capital and staff for more advanced clinical AI. They also create a digital foundation (structured call data, standardized workflows) for future AI augmentation.
• Digital mental and behavioral health see renewed funding. Lantern’s $30M raise to expand across employers and health plans reflects sustained appetite for scalable behavioral health solutions. Employer and payer distribution gives these platforms leverage to become integration points for claims, EHR, and patient‑reported outcomes data. As digital therapeutics and coaching tools mature, the line between wellness and regulated clinical interventions will blur, creating opportunities for robust, interoperable data and analytics layers.

Discussion: This is a good week to double‑down on ‘boring but bankable’ automation (access, RCM, workforce) while positioning precision health and behavioral platforms for deeper data and AI integration.

Tech Implications

• From AI pilots to governed clinical platforms. HIMSS26 discussions and HIMSSCast’s push for national AI standards in patient care underscore that ad‑hoc deployments are no longer acceptable. Health systems are being urged to align AI design with real‑world nursing workflows and to adopt shared standards for validation, monitoring, and bias. Architecturally, this points toward centralized model registries, feature stores, and policy‑driven deployment pipelines that can coexist with EHRs, telehealth, and ancillary systems, with clear lines of clinical accountability.
• Interoperability and fax‑free claims accelerate FHIR. CMS’s move to phase out fax and paper documentation for claims will force providers, payers, and vendors to modernize prior auth, claims attachments, and supporting documentation exchange. While details are still emerging, the direction of travel is toward FHIR‑based APIs, standardized document payloads, and tighter integration between EHRs, clearinghouses, and utilization management tools. Systems still reliant on bespoke HL7 v2 messages and manual uploads will feel growing friction and compliance risk.
• Cyber events push zero‑trust for devices and endpoints. The Stryker/Intune incident, combined with broader warnings on privacy and cybersecurity, highlights the need to treat device management, MDM, and remote configuration planes as high‑value assets. For connected devices, home monitoring, and AI‑enabled home care platforms, zero‑trust principles—strong identity, least privilege, continuous verification—must extend beyond the data center into clinics and patient homes. Engineering teams will need to embed security controls and telemetry into device and edge architectures by design.

Discussion: Engineering leaders should prioritize an enterprise AI platform layer, FHIR‑first interfaces for claims and clinical data, and a zero‑trust security model that explicitly covers devices, MDM, and home‑based care.

CTO Action Items

Recast your AI portfolio this quarter from a set of pilots into a governed platform: define a system‑wide AI architecture, model registry, and clinical governance council that includes nursing and compliance. Start a gap assessment on interoperability and claims workflows with an eye toward CMS’s fax‑free requirements—prioritize FHIR‑based APIs and document exchange where you’re still reliant on paper, fax, or custom HL7. Use the current budget pressure to fund automation with clear ROI, such as voice AI for patient access and remote workforce tooling, and redirect savings into higher‑risk precision health and behavioral AI bets. Finally, run a red‑team style review of your device and endpoint management stack, ensuring identity, access controls, and monitoring around MDM/Intune‑like systems are hardened, especially for connected medical devices and home‑care deployments.